We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Highlights.
- Abstract
GLO:1V0/01feb21:cpt2139-fig-0001.jpg PHOTO (COLOR): . gl Clinical utility index (CUI) calculations use a drug's efficacy and safety attributes to quantitatively assess new drugs' risk-benefit or to characterize a patient's response to therapy. To achieve individualized drug dosing in a real-world setting, the selection of a personalized dose for an individual patient should also be informed by the patient's preferences for the attributes of a medical therapy. I J. Med i . https://doi.org/10.1056/NEJMoa2027892 Credit: Getty Images A Deep-Learning Model for Cancer Therapies GLO:1V0/01feb21:cpt2139-fig-0004.jpg PHOTO (COLOR): . gl Most drugs entering clinical trials fail, often because the drug mechanism response is not fully understood.
- Subjects
CLINICAL drug trials
- Publication
Clinical Pharmacology & Therapeutics, 2021, Vol 109, Issue 2, p283
- ISSN
0009-9236
- Publication type
Article
- DOI
10.1002/cpt.2139